

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | androgen metabolic process (GO:0008209) | 9.80611733 |
| 2 | positive regulation of growth hormone secretion (GO:0060124) | 9.52613649 |
| 3 | multi-organism reproductive process (GO:0044703) | 9.35484635 |
| 4 | glucocorticoid metabolic process (GO:0008211) | 7.99808240 |
| 5 | hormone biosynthetic process (GO:0042446) | 7.24576730 |
| 6 | regulation of growth hormone secretion (GO:0060123) | 6.78248516 |
| 7 | myoblast fusion (GO:0007520) | 6.33760337 |
| 8 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 6.31677078 |
| 9 | collecting duct development (GO:0072044) | 6.23361266 |
| 10 | vitamin transmembrane transport (GO:0035461) | 6.21758556 |
| 11 | response to gonadotropin (GO:0034698) | 6.13533693 |
| 12 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 6.04981772 |
| 13 | syncytium formation (GO:0006949) | 5.89842614 |
| 14 | syncytium formation by plasma membrane fusion (GO:0000768) | 5.63822152 |
| 15 | positive regulation of protein kinase C signaling (GO:0090037) | 5.37100724 |
| 16 | endocrine hormone secretion (GO:0060986) | 5.18015668 |
| 17 | negative regulation of activin receptor signaling pathway (GO:0032926) | 5.12906573 |
| 18 | lymphangiogenesis (GO:0001946) | 4.80124768 |
| 19 | sphingoid metabolic process (GO:0046519) | 4.79566522 |
| 20 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.66763392 |
| 21 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.65908124 |
| 22 | bone morphogenesis (GO:0060349) | 4.33973301 |
| 23 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.16528420 |
| 24 | T-helper 1 type immune response (GO:0042088) | 4.16359663 |
| 25 | protein neddylation (GO:0045116) | 4.15943902 |
| 26 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 4.10045902 |
| 27 | lymph vessel development (GO:0001945) | 4.07096854 |
| 28 | estrogen biosynthetic process (GO:0006703) | 32.7963625 |
| 29 | myelin maintenance (GO:0043217) | 3.94528695 |
| 30 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.62474446 |
| 31 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.41367189 |
| 32 | cellular hormone metabolic process (GO:0034754) | 3.40957526 |
| 33 | interkinetic nuclear migration (GO:0022027) | 3.40711843 |
| 34 | parturition (GO:0007567) | 3.34512731 |
| 35 | regulation of endocrine process (GO:0044060) | 3.34389968 |
| 36 | JAK-STAT cascade (GO:0007259) | 3.29365362 |
| 37 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.27521391 |
| 38 | sprouting angiogenesis (GO:0002040) | 3.26801076 |
| 39 | eyelid development in camera-type eye (GO:0061029) | 3.13938458 |
| 40 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.12741323 |
| 41 | regulation of G0 to G1 transition (GO:0070316) | 3.07651842 |
| 42 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.06923723 |
| 43 | keratinocyte development (GO:0003334) | 3.04844820 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01722868 |
| 45 | iron ion import (GO:0097286) | 2.88425831 |
| 46 | steroid biosynthetic process (GO:0006694) | 2.82348411 |
| 47 | ear development (GO:0043583) | 2.74557529 |
| 48 | progesterone metabolic process (GO:0042448) | 2.66976740 |
| 49 | mitotic cytokinesis (GO:0000281) | 2.64292086 |
| 50 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.64089611 |
| 51 | basement membrane organization (GO:0071711) | 2.63461172 |
| 52 | transcytosis (GO:0045056) | 2.56651097 |
| 53 | polarized epithelial cell differentiation (GO:0030859) | 2.51492077 |
| 54 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.51092015 |
| 55 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.44819186 |
| 56 | regulation of protein kinase C signaling (GO:0090036) | 2.42822279 |
| 57 | sphingosine metabolic process (GO:0006670) | 2.36710826 |
| 58 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.34041790 |
| 59 | ketone biosynthetic process (GO:0042181) | 2.33869285 |
| 60 | Sertoli cell development (GO:0060009) | 2.33190735 |
| 61 | hormone metabolic process (GO:0042445) | 2.31068506 |
| 62 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.28961686 |
| 63 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.18447435 |
| 64 | regulation of ruffle assembly (GO:1900027) | 2.15617931 |
| 65 | negative regulation of macrophage differentiation (GO:0045650) | 2.15356292 |
| 66 | response to phenylpropanoid (GO:0080184) | 2.13194254 |
| 67 | blood vessel morphogenesis (GO:0048514) | 2.10815087 |
| 68 | response to inactivity (GO:0014854) | 2.10712227 |
| 69 | regulation of activin receptor signaling pathway (GO:0032925) | 2.10201865 |
| 70 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.08079760 |
| 71 | diol metabolic process (GO:0034311) | 2.07954058 |
| 72 | positive regulation of T cell cytokine production (GO:0002726) | 2.06580442 |
| 73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.01915367 |
| 74 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.01099848 |
| 75 | response to follicle-stimulating hormone (GO:0032354) | 15.7052413 |
| 76 | female pregnancy (GO:0007565) | 14.8121421 |
| 77 | regulation of gonadotropin secretion (GO:0032276) | 14.2034923 |
| 78 | estrogen metabolic process (GO:0008210) | 14.1095322 |
| 79 | glucocorticoid biosynthetic process (GO:0006704) | 13.5701868 |
| 80 | prostate gland growth (GO:0060736) | 13.3488194 |
| 81 | androgen biosynthetic process (GO:0006702) | 11.3311639 |
| 82 | multi-multicellular organism process (GO:0044706) | 10.7313626 |
| 83 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.99925050 |
| 84 | apical protein localization (GO:0045176) | 1.99741713 |
| 85 | mating behavior (GO:0007617) | 1.95842843 |
| 86 | female genitalia development (GO:0030540) | 1.94803881 |
| 87 | vitamin D metabolic process (GO:0042359) | 1.94117312 |
| 88 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.91193107 |
| 89 | thyroid hormone generation (GO:0006590) | 1.90996893 |
| 90 | Leydig cell differentiation (GO:0033327) | 1.88920138 |
| 91 | negative regulation of Ras protein signal transduction (GO:0046580) | 1.88880922 |
| 92 | lung vasculature development (GO:0060426) | 1.88385761 |
| 93 | response to vitamin E (GO:0033197) | 1.87087688 |
| 94 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.86260335 |
| 95 | negative regulation of small GTPase mediated signal transduction (GO:0051058) | 1.82478578 |
| 96 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 1.79665549 |
| 97 | cellular response to gonadotropin stimulus (GO:0071371) | 1.79637059 |
| 98 | protein targeting to Golgi (GO:0000042) | 1.79609475 |
| 99 | negative regulation of myoblast differentiation (GO:0045662) | 1.79269154 |
| 100 | neuronal ion channel clustering (GO:0045161) | 1.78472860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19032775_ChIP-ChIP_M12_Human | 5.91007224 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.48889313 |
| 3 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 3.10725447 |
| 4 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.98287417 |
| 5 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.89585407 |
| 6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.62486310 |
| 7 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.56952707 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.53123131 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.44431370 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24098074 |
| 11 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.20225150 |
| 12 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.09455777 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 13.5371125 |
| 14 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.99856933 |
| 15 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.95703348 |
| 16 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.95645894 |
| 17 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.91758575 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86872161 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81179943 |
| 20 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.79902599 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76371397 |
| 22 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.74422351 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72237157 |
| 24 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.64950623 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.54083683 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.53303910 |
| 27 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41462343 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38558222 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38558222 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37416264 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32402196 |
| 32 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.28613692 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28295460 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27644643 |
| 35 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.26500108 |
| 36 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25262129 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25223104 |
| 38 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23147994 |
| 39 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19579090 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19517183 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.19108825 |
| 42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18719089 |
| 43 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14141300 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14141300 |
| 45 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13862459 |
| 46 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.12427778 |
| 47 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.08348189 |
| 48 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06215201 |
| 49 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.03616806 |
| 50 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.03570151 |
| 51 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02864463 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02708087 |
| 53 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00709750 |
| 54 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00709750 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00580335 |
| 56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98154775 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98015093 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97520104 |
| 59 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.96145091 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95829852 |
| 61 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.95519255 |
| 62 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.94793757 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94556350 |
| 64 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.94015984 |
| 65 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93910803 |
| 66 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93177453 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93126801 |
| 68 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90976161 |
| 69 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89802157 |
| 70 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.89349692 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 0.88656561 |
| 72 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88012887 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87593783 |
| 74 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.87512857 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87006458 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85527953 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85462595 |
| 78 | JUN_21703547_ChIP-Seq_K562_Human | 0.84587544 |
| 79 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83852380 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83815657 |
| 81 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82434848 |
| 82 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82040934 |
| 83 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.80467814 |
| 84 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.80188090 |
| 85 | AR_19668381_ChIP-Seq_PC3_Human | 0.78636125 |
| 86 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.76284761 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.76284761 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76149600 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76149600 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75329726 |
| 91 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.74597245 |
| 92 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.74513078 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74161810 |
| 94 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.73527807 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.73516134 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73060646 |
| 97 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.71805635 |
| 98 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71455977 |
| 99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.70449571 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.69611674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002163_abnormal_gland_morphology | 7.14530312 |
| 2 | MP0005379_endocrine/exocrine_gland_phen | 5.43331861 |
| 3 | MP0006276_abnormal_autonomic_nervous | 4.95700181 |
| 4 | MP0005647_abnormal_sex_gland | 3.89040527 |
| 5 | MP0010368_abnormal_lymphatic_system | 3.76215015 |
| 6 | MP0001919_abnormal_reproductive_system | 3.65751885 |
| 7 | MP0000013_abnormal_adipose_tissue | 3.09458186 |
| 8 | MP0003959_abnormal_lean_body | 2.52884799 |
| 9 | MP0001440_abnormal_grooming_behavior | 2.52280229 |
| 10 | MP0003941_abnormal_skin_development | 2.47166709 |
| 11 | MP0000003_abnormal_adipose_tissue | 2.44212491 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.25804808 |
| 13 | MP0006054_spinal_hemorrhage | 2.19815985 |
| 14 | MP0005389_reproductive_system_phenotype | 2.04823397 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.00082125 |
| 16 | MP0009697_abnormal_copulation | 11.8630221 |
| 17 | MP0001666_abnormal_nutrient_absorption | 1.90451244 |
| 18 | MP0009115_abnormal_fat_cell | 1.89052706 |
| 19 | MP0002653_abnormal_ependyma_morphology | 1.77076453 |
| 20 | MP0000613_abnormal_salivary_gland | 1.67923154 |
| 21 | MP0006138_congestive_heart_failure | 1.59422471 |
| 22 | MP0003936_abnormal_reproductive_system | 1.57035148 |
| 23 | MP0002971_abnormal_brown_adipose | 1.50208597 |
| 24 | MP0000639_abnormal_adrenal_gland | 1.44314535 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.42545768 |
| 26 | MP0000647_abnormal_sebaceous_gland | 1.40988854 |
| 27 | MP0009703_decreased_birth_body | 1.39059095 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.38056725 |
| 29 | MP0002998_abnormal_bone_remodeling | 1.35892121 |
| 30 | MP0005375_adipose_tissue_phenotype | 1.32226040 |
| 31 | MP0002075_abnormal_coat/hair_pigmentati | 1.31556811 |
| 32 | MP0003453_abnormal_keratinocyte_physiol | 1.21131038 |
| 33 | MP0001756_abnormal_urination | 1.16730807 |
| 34 | MP0005023_abnormal_wound_healing | 1.05472214 |
| 35 | MP0004947_skin_inflammation | 1.04679725 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.03731675 |
| 37 | MP0001186_pigmentation_phenotype | 0.88812459 |
| 38 | MP0005334_abnormal_fat_pad | 0.88240071 |
| 39 | MP0004085_abnormal_heartbeat | 0.86746414 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 0.84660316 |
| 41 | MP0001765_abnormal_ion_homeostasis | 0.84150202 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 0.79941290 |
| 43 | MP0003136_yellow_coat_color | 0.78769082 |
| 44 | MP0000230_abnormal_systemic_arterial | 0.77797294 |
| 45 | MP0002128_abnormal_blood_circulation | 0.77259125 |
| 46 | MP0002557_abnormal_social/conspecific_i | 0.75525604 |
| 47 | MP0001915_intracranial_hemorrhage | 0.72736535 |
| 48 | MP0000685_abnormal_immune_system | 0.71929193 |
| 49 | MP0002086_abnormal_extraembryonic_tissu | 0.70638562 |
| 50 | MP0003566_abnormal_cell_adhesion | 0.69140573 |
| 51 | MP0002972_abnormal_cardiac_muscle | 0.66491555 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 0.65628275 |
| 53 | MP0005409_darkened_coat_color | 0.65445918 |
| 54 | MP0003950_abnormal_plasma_membrane | 0.64799319 |
| 55 | MP0003567_abnormal_fetal_cardiomyocyte | 0.62314773 |
| 56 | MP0003122_maternal_imprinting | 0.61107686 |
| 57 | MP0003795_abnormal_bone_structure | 0.60747448 |
| 58 | MP0003385_abnormal_body_wall | 0.60259373 |
| 59 | MP0001340_abnormal_eyelid_morphology | 0.59458230 |
| 60 | MP0000681_abnormal_thyroid_gland | 0.57013247 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 0.55872271 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 0.54003620 |
| 63 | MP0004272_abnormal_basement_membrane | 0.53682388 |
| 64 | MP0005452_abnormal_adipose_tissue | 0.53439826 |
| 65 | MP0000367_abnormal_coat/_hair | 0.52994692 |
| 66 | MP0001119_abnormal_female_reproductive | 0.52811974 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 0.51167876 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 0.50455521 |
| 69 | MP0002210_abnormal_sex_determination | 0.50293181 |
| 70 | MP0004381_abnormal_hair_follicle | 0.49115483 |
| 71 | MP0003699_abnormal_female_reproductive | 0.49062462 |
| 72 | MP0003828_pulmonary_edema | 0.47669731 |
| 73 | MP0005076_abnormal_cell_differentiation | 0.44096552 |
| 74 | MP0000598_abnormal_liver_morphology | 0.43249258 |
| 75 | MP0009780_abnormal_chondrocyte_physiolo | 0.42989634 |
| 76 | MP0000383_abnormal_hair_follicle | 0.42928406 |
| 77 | MP0001544_abnormal_cardiovascular_syste | 0.41101477 |
| 78 | MP0005385_cardiovascular_system_phenoty | 0.41101477 |
| 79 | MP0000266_abnormal_heart_morphology | 0.40059792 |
| 80 | MP0003953_abnormal_hormone_level | 0.38612676 |
| 81 | MP0000759_abnormal_skeletal_muscle | 0.35679968 |
| 82 | MP0003724_increased_susceptibility_to | 0.34985539 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.34746217 |
| 84 | MP0002295_abnormal_pulmonary_circulatio | 0.32929309 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 0.30728655 |
| 86 | MP0001545_abnormal_hematopoietic_system | 0.30728655 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.30052162 |
| 88 | MP0003091_abnormal_cell_migration | 0.29913802 |
| 89 | MP0000747_muscle_weakness | 0.27762155 |
| 90 | MP0001929_abnormal_gametogenesis | 0.27705436 |
| 91 | MP0002925_abnormal_cardiovascular_devel | 0.27675553 |
| 92 | MP0000627_abnormal_mammary_gland | 0.26991603 |
| 93 | MP0001188_hyperpigmentation | 0.26627336 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.26165634 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 0.25964717 |
| 96 | MP0008057_abnormal_DNA_replication | 0.25368472 |
| 97 | MP0001614_abnormal_blood_vessel | 0.23757722 |
| 98 | MP0000653_abnormal_sex_gland | 0.23413215 |
| 99 | MP0010678_abnormal_skin_adnexa | 0.22460740 |
| 100 | MP0005187_abnormal_penis_morphology | 0.21874167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypergonadotropic hypogonadism (HP:0000815) | 9.11050811 |
| 2 | Upper limb muscle weakness (HP:0003484) | 8.78449792 |
| 3 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 8.67734898 |
| 4 | Abnormal pupillary function (HP:0007686) | 6.91526264 |
| 5 | Muscle fibrillation (HP:0010546) | 6.55086711 |
| 6 | Nonimmune hydrops fetalis (HP:0001790) | 6.42305311 |
| 7 | Tongue fasciculations (HP:0001308) | 6.21639963 |
| 8 | Abnormal auditory evoked potentials (HP:0006958) | 6.12941769 |
| 9 | Accelerated skeletal maturation (HP:0005616) | 6.11031961 |
| 10 | Female pseudohermaphroditism (HP:0010458) | 5.70663265 |
| 11 | Anosmia (HP:0000458) | 5.48119852 |
| 12 | Back pain (HP:0003418) | 4.63674607 |
| 13 | Lower limb asymmetry (HP:0100559) | 4.52033259 |
| 14 | Gynecomastia (HP:0000771) | 4.19584039 |
| 15 | Hypogonadotrophic hypogonadism (HP:0000044) | 3.93967013 |
| 16 | Basal cell carcinoma (HP:0002671) | 3.89071345 |
| 17 | Abnormality of the ischium (HP:0003174) | 3.88882446 |
| 18 | Bilateral microphthalmos (HP:0007633) | 3.74268476 |
| 19 | Long palpebral fissure (HP:0000637) | 3.47451359 |
| 20 | Primary amenorrhea (HP:0000786) | 3.43575485 |
| 21 | Onion bulb formation (HP:0003383) | 3.38229526 |
| 22 | Abnormal pancreas size (HP:0012094) | 3.22390685 |
| 23 | Pseudobulbar signs (HP:0002200) | 3.17145408 |
| 24 | Sex reversal (HP:0012245) | 3.11002098 |
| 25 | Abnormal sex determination (HP:0012244) | 3.11002098 |
| 26 | Long eyelashes (HP:0000527) | 3.04802990 |
| 27 | Areflexia of lower limbs (HP:0002522) | 3.02460910 |
| 28 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 3.01660428 |
| 29 | Disproportionate tall stature (HP:0001519) | 3.01120045 |
| 30 | Testicular neoplasm (HP:0010788) | 2.99658579 |
| 31 | Genu valgum (HP:0002857) | 2.95675435 |
| 32 | Abnormality of the aortic arch (HP:0012303) | 2.93581766 |
| 33 | Venous insufficiency (HP:0005293) | 2.88658652 |
| 34 | Peripheral demyelination (HP:0011096) | 2.79835905 |
| 35 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.74991516 |
| 36 | Wormian bones (HP:0002645) | 2.73787870 |
| 37 | Decreased motor nerve conduction velocity (HP:0003431) | 2.63820597 |
| 38 | Bicornuate uterus (HP:0000813) | 2.62993592 |
| 39 | Polycythemia (HP:0001901) | 2.62880407 |
| 40 | Delayed gross motor development (HP:0002194) | 2.60853932 |
| 41 | Asymmetric growth (HP:0100555) | 2.58998348 |
| 42 | Difficulty walking (HP:0002355) | 2.50763835 |
| 43 | Hyperaldosteronism (HP:0000859) | 2.40316996 |
| 44 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.39930010 |
| 45 | Venous abnormality (HP:0002624) | 2.38251229 |
| 46 | Abnormality of the pupil (HP:0000615) | 2.31097400 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.30287648 |
| 48 | Hypoplastic nipples (HP:0002557) | 2.29579569 |
| 49 | Mutism (HP:0002300) | 2.26426755 |
| 50 | Hematochezia (HP:0002573) | 2.26079116 |
| 51 | Short tibia (HP:0005736) | 2.26041171 |
| 52 | Arteriovenous malformation (HP:0100026) | 2.23506883 |
| 53 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.16970048 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16482713 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16482713 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16482713 |
| 57 | Anophthalmia (HP:0000528) | 2.16266796 |
| 58 | Annular pancreas (HP:0001734) | 2.13423302 |
| 59 | Flat cornea (HP:0007720) | 2.13102919 |
| 60 | Hypoplasia of the uterus (HP:0000013) | 2.11648713 |
| 61 | Fragile skin (HP:0001030) | 2.10277588 |
| 62 | Hyporeflexia of lower limbs (HP:0002600) | 2.09256635 |
| 63 | Distal lower limb muscle weakness (HP:0009053) | 2.05909613 |
| 64 | Aplasia of the musculature (HP:0100854) | 2.05794282 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.02266426 |
| 66 | Morphological abnormality of the middle ear (HP:0008609) | 2.01436013 |
| 67 | Capillary hemangiomas (HP:0005306) | 10.1030035 |
| 68 | Renal salt wasting (HP:0000127) | 1.97464266 |
| 69 | Decreased circulating renin level (HP:0003351) | 1.92239299 |
| 70 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.87881805 |
| 71 | Ulnar deviation of finger (HP:0009465) | 1.85131094 |
| 72 | Coarctation of aorta (HP:0001680) | 1.84452839 |
| 73 | Ectopic kidney (HP:0000086) | 1.84063699 |
| 74 | Long clavicles (HP:0000890) | 1.83879017 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 1.83822616 |
| 76 | Hypoplasia of the iris (HP:0007676) | 1.82944002 |
| 77 | Confusion (HP:0001289) | 1.82829848 |
| 78 | Severe Myopia (HP:0011003) | 1.81033108 |
| 79 | Sparse lateral eyebrow (HP:0005338) | 1.75702765 |
| 80 | Hypohidrosis (HP:0000966) | 1.74800238 |
| 81 | Eczematoid dermatitis (HP:0000976) | 1.74749538 |
| 82 | Lymphedema (HP:0001004) | 1.74393980 |
| 83 | Deep philtrum (HP:0002002) | 1.72784637 |
| 84 | Fasciculations (HP:0002380) | 1.71918511 |
| 85 | Blue sclerae (HP:0000592) | 1.71469118 |
| 86 | Cerebral aneurysm (HP:0004944) | 1.67541233 |
| 87 | Hyperpituitarism (HP:0010514) | 1.66826861 |
| 88 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.62909062 |
| 89 | Abnormality of incisor morphology (HP:0011063) | 1.62166149 |
| 90 | Aortic aneurysm (HP:0004942) | 1.61692968 |
| 91 | Breast hypoplasia (HP:0003187) | 1.61360495 |
| 92 | Myotonia (HP:0002486) | 1.61068075 |
| 93 | Abnormal lung lobation (HP:0002101) | 1.59503831 |
| 94 | Abnormality of secondary sexual hair (HP:0009888) | 1.53563814 |
| 95 | Abnormality of the axillary hair (HP:0100134) | 1.53563814 |
| 96 | Abnormality of the nasolacrimal system (HP:0000614) | 1.51236132 |
| 97 | Aplasia cutis congenita (HP:0001057) | 1.50595698 |
| 98 | Teleangiectasia of the skin (HP:0100585) | 1.50291776 |
| 99 | Osteolytic defects of the hand bones (HP:0009699) | 1.50256218 |
| 100 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.50256218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDGFRA | 6.64581912 |
| 2 | AKT3 | 5.85016631 |
| 3 | DAPK2 | 4.74873552 |
| 4 | BLK | 2.96749178 |
| 5 | ICK | 2.56892852 |
| 6 | PDGFRB | 2.54426711 |
| 7 | MST4 | 2.37424529 |
| 8 | KDR | 10.6190829 |
| 9 | TIE1 | 1.82637501 |
| 10 | DAPK1 | 1.73866854 |
| 11 | PKN1 | 1.52476649 |
| 12 | NEK9 | 1.25093236 |
| 13 | ERBB4 | 1.18373441 |
| 14 | DAPK3 | 1.10356217 |
| 15 | MAP3K7 | 1.07988799 |
| 16 | INSR | 1.07947707 |
| 17 | RIPK1 | 1.06549276 |
| 18 | PDPK1 | 1.05587031 |
| 19 | SRC | 1.03782132 |
| 20 | RPS6KA2 | 0.98867723 |
| 21 | EGFR | 0.93637305 |
| 22 | LATS1 | 0.90608119 |
| 23 | FRK | 0.85535052 |
| 24 | INSRR | 0.85138485 |
| 25 | RPS6KA6 | 0.75170873 |
| 26 | RPS6KL1 | 0.74067205 |
| 27 | RPS6KC1 | 0.74067205 |
| 28 | TYK2 | 0.73897055 |
| 29 | STK38 | 0.72382915 |
| 30 | FES | 0.67307620 |
| 31 | PTK6 | 0.66165604 |
| 32 | MAPK13 | 0.64446844 |
| 33 | STK10 | 0.61723318 |
| 34 | MET | 0.61088207 |
| 35 | JAK2 | 0.60823537 |
| 36 | TGFBR2 | 0.60435619 |
| 37 | YES1 | 0.59144070 |
| 38 | MARK2 | 0.59031083 |
| 39 | AKT2 | 0.57215972 |
| 40 | TRPM7 | 0.52145570 |
| 41 | PRKCZ | 0.51741794 |
| 42 | PDK1 | 0.51400419 |
| 43 | PRKD2 | 0.45814673 |
| 44 | SGK223 | 0.44007122 |
| 45 | SGK494 | 0.44007122 |
| 46 | PRKD1 | 0.42639418 |
| 47 | LYN | 0.41626013 |
| 48 | AURKB | 0.39141441 |
| 49 | EPHA2 | 0.38177749 |
| 50 | SGK1 | 0.37349012 |
| 51 | MAP2K1 | 0.37234703 |
| 52 | BRD4 | 0.37202816 |
| 53 | NME1 | 0.37058178 |
| 54 | MAPK4 | 0.36771067 |
| 55 | MTOR | 0.35670703 |
| 56 | DYRK1B | 0.34835949 |
| 57 | FER | 0.33703320 |
| 58 | CDC42BPA | 0.33693929 |
| 59 | LCK | 0.32107229 |
| 60 | MAPK11 | 0.31569273 |
| 61 | PRKCQ | 0.31031857 |
| 62 | MYLK | 0.29815641 |
| 63 | SMG1 | 0.28762360 |
| 64 | HCK | 0.28605071 |
| 65 | PRKCA | 0.26340608 |
| 66 | MELK | 0.23719047 |
| 67 | ERBB2 | 0.23468500 |
| 68 | EPHB2 | 0.23394698 |
| 69 | TXK | 0.22681999 |
| 70 | TAF1 | 0.21360701 |
| 71 | MAP3K12 | 0.20956285 |
| 72 | PRKAA1 | 0.19880510 |
| 73 | CAMK4 | 0.18956067 |
| 74 | ERBB3 | 0.18915073 |
| 75 | PTK2B | 0.18573265 |
| 76 | PRKAA2 | 0.18533289 |
| 77 | MAPK1 | 0.17869114 |
| 78 | KIT | 0.16515954 |
| 79 | PRKCE | 0.16417438 |
| 80 | MAP3K9 | 0.15086522 |
| 81 | SGK3 | 0.13979121 |
| 82 | RPS6KA1 | 0.12623883 |
| 83 | STK3 | 0.12213329 |
| 84 | STK24 | 0.12165857 |
| 85 | SGK2 | 0.11711570 |
| 86 | MAPK8 | 0.11528412 |
| 87 | MAPK3 | 0.11058204 |
| 88 | ROCK1 | 0.10268751 |
| 89 | FGFR3 | 0.10057195 |
| 90 | PRKCB | 0.09716585 |
| 91 | CAMK2G | 0.09488841 |
| 92 | ROCK2 | 0.08603560 |
| 93 | TESK2 | 0.08390964 |
| 94 | CAMK1D | 0.07774446 |
| 95 | MAP3K4 | 0.07697650 |
| 96 | TBK1 | 0.07387093 |
| 97 | MAP2K2 | 0.06407806 |
| 98 | BMPR2 | 0.06304215 |
| 99 | PIK3CA | 0.06111199 |
| 100 | CSF1R | 0.06043482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 9.72566328 |
| 2 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 8.41961507 |
| 3 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 3.07434770 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.56534091 |
| 5 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.40691972 |
| 6 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.09162311 |
| 7 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.95955649 |
| 8 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.92105530 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 1.91830141 |
| 10 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.57114077 |
| 11 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.46644634 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34506263 |
| 13 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22229977 |
| 14 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21900389 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.19263637 |
| 16 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.17957472 |
| 17 | Axon guidance_Homo sapiens_hsa04360 | 1.14649215 |
| 18 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.08028574 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05422813 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03354617 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96380143 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 0.96114834 |
| 23 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93418619 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93132876 |
| 25 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92807606 |
| 26 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91630017 |
| 27 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89744248 |
| 28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.85277020 |
| 29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82652258 |
| 30 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70859435 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69507794 |
| 32 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68521294 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67422407 |
| 34 | Malaria_Homo sapiens_hsa05144 | 0.64600495 |
| 35 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58981629 |
| 36 | Bladder cancer_Homo sapiens_hsa05219 | 0.55737001 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 0.54730903 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53526981 |
| 39 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49576382 |
| 40 | Adherens junction_Homo sapiens_hsa04520 | 0.49196541 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48811640 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48514983 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48462556 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 0.45227231 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 0.44057553 |
| 46 | Prostate cancer_Homo sapiens_hsa05215 | 0.43912159 |
| 47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43844772 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42698192 |
| 49 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42470376 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41748666 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41523682 |
| 52 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41436202 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40201294 |
| 54 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38107716 |
| 55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38072419 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36696441 |
| 57 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35591975 |
| 58 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34881690 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34177486 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33566505 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31735775 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30686618 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29601891 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.29037270 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28087507 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27198122 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26473129 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23869261 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23696687 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22365392 |
| 71 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22314397 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.21537122 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.21522106 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21014684 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.19439486 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18612861 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18393627 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.17660849 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.17143220 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.16377378 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.16115217 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.15092601 |
| 83 | Nicotine addiction_Homo sapiens_hsa05033 | 0.14877753 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.13574379 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.12990499 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.12723398 |
| 87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.12571397 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.12052317 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.11117593 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.10800894 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10207550 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10157475 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09687400 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.09657466 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.09545764 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.09396353 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.08826185 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08513299 |
| 99 | Melanogenesis_Homo sapiens_hsa04916 | 0.08251120 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.08186716 |

